Axcelis Technologies (NASDAQ: ACLS) specializes in ion implantation equipment used to make semiconductors, including AI chips. Wafer fabrication is a mandatory step in creating AI chips, and ion deposition is an important part of it.
This role has made Axcelis Technologies a key part of the AI boom, and the stock price has doubled in the year to date. While the latest financial results raise a note of caution, a closer look reveals an opportunity.
Missed Nvidia in 2009? This Rare Signal Lights Up Again. In 2009, a “Double Down” signal lit up a little-known chip maker called Nvidia. For the first time in years, that “Believe It All” signal is shining on a company 1/100 the size of Nvidia. Continue »
Axcelis Technologies is cycling out of low growth while moving into memory
Axcelis Technologies only delivered 3% year-over-year revenue growth in Q1, which doesn’t exactly befit a growth stock. However, the lower growth rate is due to a decrease in sales in what it calls “Strength and Normal Maturity” markets.
Strong sequential growth in the memory industry has helped Axcelis Technologies deliver good year-over-year revenue growth. Memory demand has driven the customer support and innovation (CS&I) division of Axcelis Technologies, with CEO Russell Low citing “strong sequential growth” continuing through 2025.
Axcelis Technologies ion implantation equipment is essential for AI data centers. It has competitors like Materials Used again Lam researchbut the business models of those companies are very different. Axcelis Technologies is probably the only pure-play ion implant stock.
Micron Technologies‘ Recent earnings results showed that the memory industry is still hot, and that momentum should carry over to Axcelis Technologies’ Q2 results’. While revenue growth is expected to be low through 2026, it could change rapidly in 2027 as memory demand becomes a larger share of Axcelis Technologies’ total revenue. Many investors bank on that situation based on recent price movements.
A merger between Axcelis Technologies and Veeco could lead to an increase in market shares
Axcelis Technologies is an all-play ion implant stock, but will expand its portfolio of services with future mergers Veeco Instruments (NASDAQ: VECO). Veeco is also on a remarkable run, its stock more than doubling year-to-date amid growing demand for AI infrastructure.
Veeco provides AI infrastructure equipment for ion implantation, including laser ablation, which is Veeco’s fastest growing business. The company has seen an increase in orders, including $250 million in equipment orders announced in May.
